REFERENCES:
1. Shikanai-Yasuda MA, Mendes RP, Colombo AL, de Queiroz-Telles F, Kono
ASG, Paniago AMM, et al. Brazilian guidelines for the clinical
management of paracoccidioidomycosis. Rev Soc Bras Med Trop.
2017;50(5):715–40.
2. Hahn RC, Rodrigues AM, Terra PP Della, Nery AF, Hoffmann-Santos HD,
Góis HM, et al. Clinical and epidemiological features of
paracoccidioidomycosis due to paracoccidioides lutzii. PLoS Negl Trop
Dis. 2019;13(6):1–13.
3. Batista M, Vermelho F, Correia AS, Suzart KK, Almeida LA, Khoury Z.
Alterações abdominais da paracoccidioidomicose disseminada.
2015;48(2):81–5.
4. PARACOCCIDIOIDOMICOSE JUVENIL MIMETIZANDO SÍNDROME COLESTÁTICA -
relato de caso. Rev científica Fagoc Saúde. 2017;II:87–90.
5. Marcio Nucci, MD, Arnaldo L Colombo M. Clinical manifestations and
diagnosis of acute/subacute paracoccidioidomycosis. Uptodate. 2021;
6. Cavalcante R de S, Sylvestre TF, Levorato AD, de Carvalho LR, Mendes
RP. Comparison between Itraconazole and Cotrimoxazole in the Treatment
of Paracoccidiodomycosis. PLoS Negl Trop Dis. 2014;8(4).
7. Travassos LR, Taborda CP, Colombo AL. Treatment options for
paracoccidioidomycosis and new strategies investigated. Expert Rev Anti
Infect Ther. 2008;6(2):251–62.
8. Instituto de Infectologia Emílio Ribas. 2013;31.
9. Vasconcellos A, Ambrósio A, Camelo CCS, Barbosa CV, Tomazatti FG,
Brazões FA de S, et al. Paracoccidioidomycosis disease
(Lutz-Splendore-Almeida) - clinical manifestations. Rev Médica Minas
Gerais. 2014;24(1):67–73.
10. Marcio Nucci, MD, Arnaldo L Colombo M. Clinical manifestations and
diagnosis of chronic pulmonary paracoccidioidomycosis. Uptodate. 2021;
11. Queiroz-Telles F, Goldani LZ, Schlamm HT, Goodrich JM,
Espinel-Ingroff A, Shikanai-Yasuda MA. An open-label comparative pilot
study of oral voriconazole and itraconazole for long-term treatment of
paracoccidioidomycosis. Clin Infect Dis. 2007;45(11):1462–9.
12. Ambrósio AVA, Camelo CCS, Barbosa CV, Tomazatti FG, Brazões FA de S,
Veloso JM, et al. Paracoccidioidomycosis disease (Lutz-Splendore-Almeida
disease): Additional workup, differential diagnosis, cure control. Rev
Médica Minas Gerais. 2014;24(1):81–92.
13. Ferreira CMSD, Souza NG de O, Tostes FM, Moutinho BD, Segheto NN.
Paracoccidioidomicose subaguda abdominal em paciente adulto
imunocompetente: relato de caso. Rev Soc Bras Clín Méd.
2013;11(2):201–3.
14. Borges SRC, Da Silva GMS, Da Costa Chambela M, De Vasconcellos De
CRO, Costa RLB, Wanke B, et al. Itraconazole vs.
trimethoprim-sulfamethoxazole: A comparative cohort study of 200
patients with paracoccidioidomycosis. Med Mycol. 2014;52(3):303–10.
15. Marcio Nucci, MD, Arnaldo L Colombo M. Treatment of
paracoccidioidomycosis. Uptodate. 2021;